The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations
Open accessAbstract
Clinical trials, whether industry, cooperative group sponsored, or investigator initiated, have an unacceptable rate of failure as a result of the inability to recruit sufficient numbers of patients. Even those trials that are completed often require time-consuming protocol amendments to achieve accrual goals. These inefficiencies in clinical trial research result in increasing costs and prolong the time needed to bring improved treatments to cancer clinical practice. TriNetX has developed a clinical research collaboration platform—deployed by a federated network of health care organizations (HCOs), pharmaceutical firms (Pharma), and contract research organizations (CROs)—to enable data-driven clinical research study design to reduce accrual failure and protocol amendment. Currently, the network extends to 55 HCOs and covers 84 million patients, mostly within the United States, but with a growing international presence. (Many of the HCOs in United States are Clinical and Translational Science Awardees and/or National Cancer Institute–designated cancer centers.) The TriNetX business model includes Pharma and the CROs as sponsors whose subscriptions financially support the network, including the software and hardware costs of the HCOs. Furthermore, as each HCO network member has their data harmonized with the TriNetX model upon joining, data sharing among them does not require any technical processes to establish connectivity. To date, on the basis of the data on the network, HCOs have been presented approximately 757 studies by Pharma and CROs, and four data-sharing subnetworks have been formed among member HCOs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adaptive design methods in clinical trials–a review
Chow, S.-C., & Chang, M. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-11 · Cited by 482
Medicine, N. L. O. (2008) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280801989377 · Cited by 468
Defining and measuring completeness of electronic health records for secondary use
Weiskopf, N. G., Hripcsak, G., Swaminathan, S., & Weng, C. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.06.010 · Cited by 367
Transparent Reporting of Data Quality in Distributed Data Networks
Kahn, M. G., Brown, J. S., Chun, A. T., Davidson, B. N., Meeker, D., Ryan, P. B., Schilling, L. M., Weiskopf, N. G., Williams, A. E., & Zozus, M. N. (2015) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1052 · Cited by 157
Cheng, S. K., Dietrich, M. S., & Dilts, D. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0133 · Cited by 124
Mini-Sentinel and Regulatory Science — Big Data Rendered Fit and Functional
Psaty, B. M., & Breckenridge, A. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1401664 · Cited by 90
Practices and perspectives on building integrated data repositories: results from a 2010 CTSA survey
MacKenzie, S. L., Wyatt, M., Schuff, R. A., Tenenbaum, J. D., & Anderson, N. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000508 · Cited by 62
Korn, E. L., Freidlin, B., Mooney, M., & Abrams, J. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5382 · Cited by 60
Bridging the Data-Sharing Divide — Seeing the Devil in the Details, Not the Other Camp
Rosenbaum, L. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1704482 · Cited by 28
London, J., Balestrucci, L., Chatterjee, D., & Zhan, T. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001846 · Cited by 20
Activating clinical trials: a process improvement approach
Martínez, D. A., Tsalatsanis, A., Yalçin, A., Zayas‐Castro, J. L., & Djulbegović, B. (2016) · Trials · doi:10.1186/s13063-016-1227-2 · Cited by 18
Franzén, S., Janson, C., Larsson, K., Petzold, M., Olsson, U., Magnusson, G., Telg, G., Colice, G., Johansson, G. S., & Sundgren, M. (2016) · Respiratory Research · doi:10.1186/s12931-016-0461-1 · Cited by 10
Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials
Rosas, S. R., Schouten, J. T., Dixon, D. O., Varghese, S., Cope, M. T., Marci, J., & Kagan, J. (2014) · Clinical Trials · doi:10.1177/1740774514540814 · Cited by 7
Cited by
A global federated real-world data and analytics platform for research
Palchuk, M. B., London, J. W., Perez-Rey, D., Drebert, Z. J., Winer-Jones, J. P., Thompson, C. N., Esposito, J., & Claerhout, B. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad035 · Cited by 948
“The initial use case for TriNetX was to accelerate clinical research by providing tools for optimizing clinical trial design and site selection.(8,19) Since the network began commercial operations in 2016, the success of the network in facilitating clinical trial collaborations can be seen in the increase in requests…”
BackgroundMethodSelf-citationThe National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
Haendel, M. A., Chute, C. G., Bennett, T. D., Eichmann, D. A., Guinney, J., Kibbe, W. A., Payne, P. R. O., Pfaff, E. R., Robinson, P. N., Saltz, J. H., et al. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa196 · Cited by 553
Self-citationEffects of the COVID-19 Pandemic on Cancer-Related Patient Encounters
London, J. W., Fazio-Eynullayeva, E., Palchuk, M. B., Sankey, P., & McNair, C. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00068 · Cited by 323
Self-citationLudwig, R. J., Anson, M., Zirpel, H., Thaci, D., Olbrich, H., Bieber, K., Kridin, K., Dempfle, A., Curman, P., Zhao, S. S., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1516126 · Cited by 254
The Cosmos Collaborative: A Vendor-Facilitated Electronic Health Record Data Aggregation Platform
Tarabichi, Y., Frees, A., Honeywell, S., Huang, C., Naidech, A. M., Moore, J. H., & Kaelber, D. C. (2021) · ACI Open · doi:10.1055/s-0041-1731004 · Cited by 139
Metadata
- Authors
- Topaloglu, U., & Palchuk, M. B.
- Venue
- JCO Clinical Cancer Informatics
- Published
- 2018-12
- Volume
- 2
- Issue
- 2
- Pages
- 1-10
- ISSN
- 2473-4276 (ISSN-L)
- OpenAlex
- W2787483926
- Cited by
- 349
- References
- 13
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.